ALBIREO PHARMA INC's ticker is ALBO and the CUSIP is 01345P106. A total of 74 filers reported holding ALBIREO PHARMA INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $1,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q2 2020 | $1,000 | – | 25 | 0.0% | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 25 | 0.0% | 0.00% | – |
| Q4 2019 | $1,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 25 | 0.0% | 0.00% | – |
| Q2 2019 | $1,000 | 0.0% | 25 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $1,000 | 0.0% | 25 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $1,000 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 491,244 | $9,510,000 | 5.10% |
| Decheng Capital Management III (Cayman), LLC | 623,342 | $12,068,000 | 4.38% |
| TANG CAPITAL MANAGEMENT LLC | 1,099,516 | $21,287,000 | 2.61% |
| Privium Fund Management B.V. | 300,252 | $5,624,000 | 2.04% |
| Birchview Capital, LP | 117,000 | $2,265,000 | 1.60% |
| Perceptive Advisors | 2,360,139 | $45,692,000 | 1.33% |
| Chicago Capital, LLC | 1,119,774 | $21,679,000 | 1.25% |
| Endurant Capital Management LP | 172,621 | $3,342,000 | 1.09% |
| Deep Track Capital, LP | 1,110,624 | $21,502,000 | 0.98% |
| SPHERA FUNDS MANAGEMENT LTD. | 359,000 | $6,950,000 | 0.96% |